[go: up one dir, main page]

US20170127941A1 - Implant for determining intraocular pressure - Google Patents

Implant for determining intraocular pressure Download PDF

Info

Publication number
US20170127941A1
US20170127941A1 US15/319,294 US201515319294A US2017127941A1 US 20170127941 A1 US20170127941 A1 US 20170127941A1 US 201515319294 A US201515319294 A US 201515319294A US 2017127941 A1 US2017127941 A1 US 2017127941A1
Authority
US
United States
Prior art keywords
implant
eye
data
pressure sensor
implant according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/319,294
Inventor
Max Ostermeier
Stefan Meyer
Prof. Peter SZURMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Implandata Ophthalmic Products GmbH
Original Assignee
Implandata Ophthalmic Products GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Implandata Ophthalmic Products GmbH filed Critical Implandata Ophthalmic Products GmbH
Assigned to IMPLANDATA OPHTHALMIC PRODUCTS GMBH reassignment IMPLANDATA OPHTHALMIC PRODUCTS GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MEYER, STEFAN, OSTERMEIER, MAX, SZURMAN, Prof. Peter
Publication of US20170127941A1 publication Critical patent/US20170127941A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/16Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring intraocular pressure, e.g. tonometers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0008Temperature signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6861Capsules, e.g. for swallowing or implanting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B2017/00831Material properties
    • A61B2017/00893Material properties pharmaceutically effective
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0204Operational features of power management
    • A61B2560/0214Operational features of power management of power generation or supply
    • A61B2560/0219Operational features of power management of power generation or supply of externally powered implanted units
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0247Pressure sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/16Details of sensor housings or probes; Details of structural supports for sensors
    • A61B2562/162Capsule shaped sensor housings, e.g. for swallowing or implantation

Definitions

  • the present invention relates to an implant for determining intraocular pressure, comprising at least one electronic pressure sensor for measuring the intraocular pressure, at least one microchip that is connected to the pressure sensor, and at least one antenna that is connected to the microchip, the microchip generating digitally encoded data from the electrical signals of the pressure sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye, and said components being accommodated in a small housing, the outer dimensions of which are limited such that the implant can be positioned between the sclera and choroid of the eye.
  • U.S. Pat. No. 8,475,374 B2 discloses an implant of this type.
  • This known implant comprises an artificial drainage tube or is in contact with an artificial drainage tube for watery ocular fluid in order to measure the pressure of the outflowing ocular fluid.
  • an artificial drainage tube is associated with a considerable and risky intervention in the eye.
  • U.S. Pat. No. 7,824,423 B2 discloses a surgical tool for inserting implants into the eye. Moreover, this US patent discloses inserting implants into the eye that are used for scleral prosthesis and that increase the working range of the ciliary muscles in a purely mechanical manner in order to make it easier for the eye treated in this way to focus on nearby objects if the amplitude of accommodation has already declined due to age.
  • the object of the invention is to provide an implant for determining intraocular pressure that can be implanted into the eye with little intervention and that transmits measurement data of the highly accurately measured intraocular pressure to a receiver located outside the eye.
  • the pressure sensor is accommodated on the outer housing side that is brought into contact with the choroid in the eye.
  • the implant according to the invention can be implanted into human or animal eyes in a minimally invasive manner and can remain there as a long-term implant.
  • the implant is designed according to the invention such that it can be accommodated in a suprachoroidal cavity of the eye created for positioning the implant between the sclera and choroid, where said implant does not interfere with the functioning of the eye. Neither an artificial lens nor an artificial drainage tube for the ocular fluid is necessary. Nevertheless, the contact of the pressure sensor on the choroid ensures that the intraocular pressure is applied to the pressure sensor and can be measured accurately.
  • the implantation is carried out either by means of a separate implantation procedure or in combination with other ophthalmosurgical interventions such as penetrating or non-penetrating glaucoma surgery (e.g. trabeculectomy, (visco)canaloplasty or shunt implantation).
  • ophthalmosurgical interventions such as penetrating or non-penetrating glaucoma surgery (e.g. trabeculectomy, (visco)canaloplasty or shunt implantation).
  • the outer housing side equipped with the pressure sensor to comprise a flexible membrane in the region of the pressure sensor as a protective layer against ingress of fluid, the intraocular pressure acting on the pressure sensor via the choroid and the membrane.
  • the flexible membrane ensures precise transfer of the intraocular pressure, which could otherwise be distorted by housing-induced mechanical tensions if a less flexible housing material were used.
  • the implant housing is flat and elongate, preferably in the form of an ellipsoid or cuboid having rounded corners and edges. By rounding off the edges and corners, eye injuries can be prevented.
  • the implant In order to preserve ocular integrity, the implant must be as flat as possible, since relatively little space can be created between the sclera and the choroid. The thickness of the implant is therefore the smallest dimension thereof and should be less than 2 mm if possible.
  • the front face should not be too big either, in order for the scleral incision necessary for inserting the implant to be as small as possible.
  • the width of the implant is therefore preferably less than 3.5 mm.
  • the largest dimension is the length of the implant, which should preferably be less than 7 mm in order to minimise the biomechanical influences on the eye as well as on the implant.
  • the implant Due to its flat shape, the implant cannot rotate about its longitudinal axis within the pocket between the sclera and choroid in the eye. Only rotations about the vertical axis (see direction of rotation 32 in FIG. 3 ) are possible. These rotations can be performed after the implant has been inserted if it is desirable to arrange the longitudinal axis of the implant transversely to the viewing direction of the eye.
  • the implant is normally inserted into the eye lengthways in the viewing direction of the eye by means of a scleral cut.
  • the implant does not rotate spontaneously in the eye.
  • the implant housing can be provided with suture loops on the outside for fixing the implant in the eye.
  • the fastening could, for example, be designed such that closure of the implantation suture is used at the same time to fix the implant in place.
  • a suture loop could be provided at the point where the implantation aperture is closed using a suture.
  • an adhesion option can be provided on the implant, by means of which said implant is fixed in place as soon as the implantation aperture is closed using a biological adhesive.
  • the implant housing is moulded from plastics material.
  • the inner components such as the microchip, pressure sensor and antenna, etc. can be cast and fixed in the plastics material.
  • moulding the housing from plastics material allows it to be shaped in a particularly simple manner, in particular into an ellipsoid or cuboid having rounded corners and edges.
  • the implant could be coated with a pharmacologically active substance, e.g. heparin, mytocin C or another substance, in order to prevent reactions such as inflammation, coagulation, tissue formation or encapsulation that would be problematic either for the eye or for pressure measurement.
  • a pharmacologically active substance e.g. heparin, mytocin C or another substance, in order to prevent reactions such as inflammation, coagulation, tissue formation or encapsulation that would be problematic either for the eye or for pressure measurement.
  • the housing can be concave on the outer housing side thereof facing the choroid, as a result of which in particular deformation of the implant or mechanical tension caused by the eye, which would distort the pressure measurement, is prevented.
  • Embodiments having straight or convex outer housing sides are also included in the invention.
  • the implant housing comprises three nubs on the outer housing side thereof facing the sclera, which nubs are arranged in the manner of the corners of a triangle and are intended to come into contact with the sclera.
  • the shape of the nubs can be round or pointed and thus form a soft “thorn” which prevents dislocation and torsion of the implant.
  • the nubs also ensure that the implant cannot tilt and that no part of the implant other than the nubs comes into contact with the concave inner surface of the sclera. As a result, it is not necessary to adapt the outer contour of the sclera-side of the implant to different eye sizes. It has been found that the mechanical tension in the implant caused by bending can be greatly reduced by the arrangement of the nubs according to the invention.
  • the invention is further improved by providing the implant with an electronic temperature sensor that is connected to the microchip and is intended for measuring the temperature of the eye, the microchip generating data from the electrical signals of the temperature sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye.
  • the microchip generating data from the electrical signals of the temperature sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye.
  • a further embodiment of the invention provides for the antenna to consist of an electrical coil that surrounds the microchip provided with the pressure sensor.
  • a telemetry coil of this type is particularly well suited for transmitting data to a receiver arranged outside the eye.
  • the coil can be produced by electroplating in that a plurality of layers of the coil are electrodeposited onto a flexible or rigid, but thin, substrate.
  • Another embodiment consists of a thin insulated gold wire that is wound around the microchip directly or on integrated spacers. This gives the external coil arranged outside the eye a shape that allows optimal transformer coupling to the implant.
  • the contour of the external coil can be two-dimensionally or three-dimensionally adapted to the position of the electrical coil in the implant.
  • the microchip in the implant can thus be designed in the manner of a RFID chip, such that the implant does not need a separate battery as a power source.
  • the energy for transmitting the data from the implant to the external receiver is provided by means of the receiving antenna itself emitting a brief energy burst that is temporarily stored in the microchip of the implant for a short time in order to provide the energy for the subsequent transmission process.
  • the energy can also be supplied continuously throughout the measurement or data transmission process.
  • the implant can operate in the manner of an active RFID tag and carry out measurements autonomously, the results of which are saved and only transmitted to an occasionally used reader upon request.
  • the implant requires an energy store that is charged by means of transformer coupling or energy harvesting (saccades) for example, or also by means of optical cells that are sensitive to wavelengths for which the human sclera is transparent.
  • An autonomous system of this type would either have its own clock generator or would use the frequencies of ubiquitous GSM signals as the clock frequency.
  • the reader could provide the trigger for a measurement via a radio link. No short-range transformer coupling is necessary for this. It is sufficient for the reader to be positioned at a distance of approximately one metre from the implant.
  • the reader measures and records the external air pressure together with and at the same time as the measurement values for the intraocular pressure.
  • a quasi-continuous recording of air pressure values can also be achieved without any contact with the implant if said implant saves the measured intraocular pressure values together with a time stamp, for example in a data logger. After the occasional reading of the data logger, the measurement values for the intraocular pressure can be assigned to the same point in time as the air pressure values measured and recorded by the reader.
  • An implant 1 according to the invention is shown in all figures and is intended to be implanted in an animal or human eye 2 .
  • the outer wall of the eye 2 is formed by the sclera 3 , the inner side of which is adjacent to the choroid 4 that lies beneath it.
  • the implant 1 lies in a cavity 5 that is shaped like a pocket and is formed in the suprachoroidal region between the sclera 3 and the choroid 4 .
  • the implant 1 can be positioned ab interno transversely through the anterior chamber of the eye 2 by means of a surgical approach through the iridocorneal angle to the implantation site.
  • the implant can be positioned through the sclera 3 by making the smallest incision possible, in practice approximately 5 mm long, through the sclera 3 .
  • the incision can either extend directly perpendicularly, which may require subsequent wound closure, or it can be a lamellar incision and therefore self-closing.
  • the incision is made in the region of or behind the pars plana, for example in parallel with the ora serrata.
  • a cavity or pocket 5 is formed in the suprachoroidal space between the sclera 3 and the choroid 4 , using a viscoelastics material such as hyaluronic acid which is injected using an atraumatic cannula.
  • the implant 1 can now be introduced into the pocket 5 using forceps or the insertion tool 20 described below. If required, the implant 1 is rotated inside the pocket 5 in the direction of rotation 32 by 90° about its vertical axis, which is possible due to the fact that the different layers of the eyeball merely lie on top of one another but are not stuck together.
  • the stability of the eye's shape is due to the intraocular pressure.
  • Rotating the implant has the advantage of allowing the telemetry coil 8 contained in the implant to be brought into an advantageous position, as far forward as possible and directly behind the pars plana, the long side being in parallel therewith.
  • the implant 1 is thus either in parallel with the viewing direction 9 and therefore aligned with the optical axis of the eye 2 , or it is rotated by 90° relative to the viewing direction 9 and therefore oriented in parallel with the pars plana.
  • the aim is to position the implant as far forward as possible so that it can be reached as easily as possible by the telemetry.
  • the surgically produced sclera aperture does not necessarily have to be closed after the implant 1 has been positioned. Normally, the sclera will grow back of its own accord without further intervention. If required, however, it can be closed by means of a suture, biological adhesive, or the like.
  • the implant 1 has an electrical pressure sensor 6 for measuring the intraocular pressure, a microchip 7 on which the pressure sensor 6 is attached and connected to the microchip 7 , and an antenna 8 in the form of an electrical coil that is made of insulating gold wire and supported by spacers 10 .
  • the gold wire is wound around the microchip 7 in a plurality of turns.
  • the housing 11 of the implant 1 is moulded from synthetic resin or formed of silicone rubber, the above-mentioned components being enclosed therein.
  • the implant could, for example, be embedded in a plurality of layers of silicone rubber having varying degrees of hardness in order to achieve greater stability.
  • a sensor-side layer is made of softer material and a back layer is made of harder material.
  • the housing 11 is flat and elongate and is in the shape of a cuboid having rounded corners and edges, and nubs on one housing side.
  • the length 12 of the housing 11 is approximately 6 mm, its width 13 is approximately 3 mm and its thickness 14 is approximately 1.5 mm.
  • the housing 11 is provided with three nubs 17 on an outer housing side 15 that faces the sclera 3 of the eye 2 in the implanted state, the nubs being arranged in the manner of the corners of a triangle.
  • the same implant 1 can be used for eyes 2 of varying sizes, the sclera 3 of which is concavely curved to varying degrees on its inner side without the degree of curvature having a significant influence on the mechanical tension to which the implant 1 is exposed in the eye 2 .
  • the accuracy of the pressure measurement is improved.
  • the pressure sensor 6 is arranged on the other outer housing side 16 of the housing 11 that faces the choroid 4 in the implanted state.
  • a flexible membrane 18 is located between the pressure sensor 6 and the choroid 4 as a protective layer against ingress of liquid. The membrane 18 presses against the pressure-sensitive surface of the pressure sensor 6 and, on the other side, against the choroid 4 . The pressure sensor 6 is thus in full-surface contact with the choroid 4 via the membrane 18 .
  • the implant 1 lies in the eye 2 in a tension-free manner between the sclera 3 and the choroid 4 . Due to physiological ocular pressure and force relationships, the intraocular pressure also fixes the implant 1 in place by means of the choroid 4 .
  • the choroid 4 lies on the membrane 18 of the planarly extended pressure sensor 6 as a thin, soft choroid coat. As a result, the coupling between the pressure sensor 6 and the aqueous humour of the vitreous body of the eye 2 is not, or is only insignificantly, affected.
  • the implant 1 therefore does not measure the pressure in the suprachoroidal space, but rather in the inner eye.
  • the implant 1 is provided with a temperature sensor 19 that is attached to the microchip 7 .
  • the temperature sensor 19 is used for measuring the temperature of the eye in the suprachoroidal space.
  • the electrical signals of the temperature sensor 19 are registered by the microchip 7 and digital data are generated in which the temperature values and pressure values are encoded.
  • the digital data are transmitted by the antenna 8 , using electromagnetic waves, to a receiver located outside the eye 2 .
  • the pressure and temperature data can be saved in and analysed by the receiver. Analysis of the temporal progression of the pressure or temperature is thus also possible.
  • the outer housing side 16 of the housing 11 of the implant 1 that faces the choroid can be concave.
  • the outer housing side 15 of the housing 11 opposite the sclera 3 is convex in the embodiment shown.
  • the design can take one form or the other, depending on the requirements.
  • the convex and concave sides can also be arranged vice versa, or both sides can be convex or both sides can be concave.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physiology (AREA)
  • Prostheses (AREA)
  • Eye Examination Apparatus (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

An implant for determining intraocular pressure includes at least one electrical pressure sensor for measuring the intraocular pressure, at least one microchip that is connected to the pressure sensor, and at least one antenna that is connected to the microchip, the microchip generating digitally encoded data from the electrical signals of the pressure sensor, which data can be transmitted by an antenna, using electromagnetic waves, to a receiver located outside the eye, and components being accommodated in a small housing, the outer dimensions of which are limited such that the implant can be positioned between the sclera and the choroid of the eye, is improved in that the pressure sensor is accommodated on an outer housing side of the implant, which outer housing side is brought into contact with the choroid in the eye.

Description

  • The present invention relates to an implant for determining intraocular pressure, comprising at least one electronic pressure sensor for measuring the intraocular pressure, at least one microchip that is connected to the pressure sensor, and at least one antenna that is connected to the microchip, the microchip generating digitally encoded data from the electrical signals of the pressure sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye, and said components being accommodated in a small housing, the outer dimensions of which are limited such that the implant can be positioned between the sclera and choroid of the eye.
  • U.S. Pat. No. 8,475,374 B2 discloses an implant of this type. This known implant comprises an artificial drainage tube or is in contact with an artificial drainage tube for watery ocular fluid in order to measure the pressure of the outflowing ocular fluid. However, an artificial drainage tube is associated with a considerable and risky intervention in the eye.
  • DE 197 28 069 C1 discloses an implant in which the pressure sensor is contained in an implantable intraocular lens that is inserted into the eye in place of the natural lens. This known implant is therefore not suitable for cases where the natural lens of the eye should be retained.
  • U.S. Pat. No. 7,824,423 B2 discloses a surgical tool for inserting implants into the eye. Moreover, this US patent discloses inserting implants into the eye that are used for scleral prosthesis and that increase the working range of the ciliary muscles in a purely mechanical manner in order to make it easier for the eye treated in this way to focus on nearby objects if the amplitude of accommodation has already declined due to age.
  • The object of the invention is to provide an implant for determining intraocular pressure that can be implanted into the eye with little intervention and that transmits measurement data of the highly accurately measured intraocular pressure to a receiver located outside the eye.
  • This object is achieved by the invention in that the pressure sensor is accommodated on the outer housing side that is brought into contact with the choroid in the eye. The implant according to the invention can be implanted into human or animal eyes in a minimally invasive manner and can remain there as a long-term implant. The implant is designed according to the invention such that it can be accommodated in a suprachoroidal cavity of the eye created for positioning the implant between the sclera and choroid, where said implant does not interfere with the functioning of the eye. Neither an artificial lens nor an artificial drainage tube for the ocular fluid is necessary. Nevertheless, the contact of the pressure sensor on the choroid ensures that the intraocular pressure is applied to the pressure sensor and can be measured accurately.
  • The implantation is carried out either by means of a separate implantation procedure or in combination with other ophthalmosurgical interventions such as penetrating or non-penetrating glaucoma surgery (e.g. trabeculectomy, (visco)canaloplasty or shunt implantation).
  • In a development of the invention it is provided for the outer housing side equipped with the pressure sensor to comprise a flexible membrane in the region of the pressure sensor as a protective layer against ingress of fluid, the intraocular pressure acting on the pressure sensor via the choroid and the membrane. The flexible membrane ensures precise transfer of the intraocular pressure, which could otherwise be distorted by housing-induced mechanical tensions if a less flexible housing material were used.
  • In a preferred embodiment, the implant housing is flat and elongate, preferably in the form of an ellipsoid or cuboid having rounded corners and edges. By rounding off the edges and corners, eye injuries can be prevented. In order to preserve ocular integrity, the implant must be as flat as possible, since relatively little space can be created between the sclera and the choroid. The thickness of the implant is therefore the smallest dimension thereof and should be less than 2 mm if possible.
  • The front face should not be too big either, in order for the scleral incision necessary for inserting the implant to be as small as possible. The width of the implant is therefore preferably less than 3.5 mm.
  • The largest dimension is the length of the implant, which should preferably be less than 7 mm in order to minimise the biomechanical influences on the eye as well as on the implant.
  • Due to its flat shape, the implant cannot rotate about its longitudinal axis within the pocket between the sclera and choroid in the eye. Only rotations about the vertical axis (see direction of rotation 32 in FIG. 3) are possible. These rotations can be performed after the implant has been inserted if it is desirable to arrange the longitudinal axis of the implant transversely to the viewing direction of the eye. The implant is normally inserted into the eye lengthways in the viewing direction of the eye by means of a scleral cut.
  • Usually, the implant does not rotate spontaneously in the eye. If, exceptionally, there is nonetheless a risk of rotation, the implant housing can be provided with suture loops on the outside for fixing the implant in the eye. The fastening could, for example, be designed such that closure of the implantation suture is used at the same time to fix the implant in place. For this purpose, a suture loop could be provided at the point where the implantation aperture is closed using a suture. Alternatively, an adhesion option can be provided on the implant, by means of which said implant is fixed in place as soon as the implantation aperture is closed using a biological adhesive.
  • In a preferred embodiment the implant housing is moulded from plastics material. In this way, the inner components such as the microchip, pressure sensor and antenna, etc. can be cast and fixed in the plastics material. Furthermore, moulding the housing from plastics material allows it to be shaped in a particularly simple manner, in particular into an ellipsoid or cuboid having rounded corners and edges.
  • The implant could be coated with a pharmacologically active substance, e.g. heparin, mytocin C or another substance, in order to prevent reactions such as inflammation, coagulation, tissue formation or encapsulation that would be problematic either for the eye or for pressure measurement.
  • In a variant, the housing can be concave on the outer housing side thereof facing the choroid, as a result of which in particular deformation of the implant or mechanical tension caused by the eye, which would distort the pressure measurement, is prevented. Embodiments having straight or convex outer housing sides are also included in the invention.
  • The shape of the implant side facing the inner surface of the sclera can lead to unexpected variations in the pressure measurement, e.g. as a result of cell proliferation or encapsulation reactions of the body. It is therefore proposed for the implant housing to comprise three nubs on the outer housing side thereof facing the sclera, which nubs are arranged in the manner of the corners of a triangle and are intended to come into contact with the sclera. The shape of the nubs can be round or pointed and thus form a soft “thorn” which prevents dislocation and torsion of the implant. The nubs also ensure that the implant cannot tilt and that no part of the implant other than the nubs comes into contact with the concave inner surface of the sclera. As a result, it is not necessary to adapt the outer contour of the sclera-side of the implant to different eye sizes. It has been found that the mechanical tension in the implant caused by bending can be greatly reduced by the arrangement of the nubs according to the invention.
  • The invention is further improved by providing the implant with an electronic temperature sensor that is connected to the microchip and is intended for measuring the temperature of the eye, the microchip generating data from the electrical signals of the temperature sensor, which data can be transmitted by the antenna, using electromagnetic waves, to a receiver located outside the eye. Specifically, scientific investigations have found that there can be steep temperature gradients inside the eye. The temperature measured in the anterior chamber or in the posterior chamber is thus different from the suprachoroidal temperature. This suprachoroidal temperature can be measured and recorded together with the hydrostatic and hydrodynamic fluid pressure in the eye using the implant according to the invention. Supplementing the pressure monitoring with temperature monitoring allows better conclusions to be drawn regarding ocular pathologies or general diseases, for example diseases of the retina or disorders of general thermoregulation of the patient.
  • A further embodiment of the invention provides for the antenna to consist of an electrical coil that surrounds the microchip provided with the pressure sensor. A telemetry coil of this type is particularly well suited for transmitting data to a receiver arranged outside the eye. The coil can be produced by electroplating in that a plurality of layers of the coil are electrodeposited onto a flexible or rigid, but thin, substrate.
  • Another embodiment consists of a thin insulated gold wire that is wound around the microchip directly or on integrated spacers. This gives the external coil arranged outside the eye a shape that allows optimal transformer coupling to the implant. The contour of the external coil can be two-dimensionally or three-dimensionally adapted to the position of the electrical coil in the implant.
  • The microchip in the implant can thus be designed in the manner of a RFID chip, such that the implant does not need a separate battery as a power source. The energy for transmitting the data from the implant to the external receiver is provided by means of the receiving antenna itself emitting a brief energy burst that is temporarily stored in the microchip of the implant for a short time in order to provide the energy for the subsequent transmission process.
  • However, the energy can also be supplied continuously throughout the measurement or data transmission process.
  • In an alternative embodiment, the implant can operate in the manner of an active RFID tag and carry out measurements autonomously, the results of which are saved and only transmitted to an occasionally used reader upon request. In this case, the implant requires an energy store that is charged by means of transformer coupling or energy harvesting (saccades) for example, or also by means of optical cells that are sensitive to wavelengths for which the human sclera is transparent. An autonomous system of this type would either have its own clock generator or would use the frequencies of ubiquitous GSM signals as the clock frequency. The reader could provide the trigger for a measurement via a radio link. No short-range transformer coupling is necessary for this. It is sufficient for the reader to be positioned at a distance of approximately one metre from the implant.
  • It is particularly expedient if the reader measures and records the external air pressure together with and at the same time as the measurement values for the intraocular pressure. A quasi-continuous recording of air pressure values can also be achieved without any contact with the implant if said implant saves the measured intraocular pressure values together with a time stamp, for example in a data logger. After the occasional reading of the data logger, the measurement values for the intraocular pressure can be assigned to the same point in time as the air pressure values measured and recorded by the reader.
  • Embodiments of the invention are explained in more detail below with reference to the figures, in which, in detail:
      • FIG. 1 is a cross section of an eye comprising an inserted implant;
      • FIG. 2 is a detail A from FIG. 1 comprising the implant inserted in a pocket between the sclera and choroid;
      • FIG. 3 is a greatly enlarged plan view of an implant according to the invention;
      • FIG. 4 is a side view of the implant from FIG. 3;
      • FIG. 5 is a side view of a second embodiment of the implant having concave and convex lateral faces.
  • An implant 1 according to the invention is shown in all figures and is intended to be implanted in an animal or human eye 2. The outer wall of the eye 2 is formed by the sclera 3, the inner side of which is adjacent to the choroid 4 that lies beneath it. As can be seen best in FIG. 2, the implant 1 lies in a cavity 5 that is shaped like a pocket and is formed in the suprachoroidal region between the sclera 3 and the choroid 4.
  • The implant 1 can be positioned ab interno transversely through the anterior chamber of the eye 2 by means of a surgical approach through the iridocorneal angle to the implantation site. Alternatively, the implant can be positioned through the sclera 3 by making the smallest incision possible, in practice approximately 5 mm long, through the sclera 3. In this way, the incision can either extend directly perpendicularly, which may require subsequent wound closure, or it can be a lamellar incision and therefore self-closing. The incision is made in the region of or behind the pars plana, for example in parallel with the ora serrata. Subsequently, a cavity or pocket 5 is formed in the suprachoroidal space between the sclera 3 and the choroid 4, using a viscoelastics material such as hyaluronic acid which is injected using an atraumatic cannula. The implant 1 can now be introduced into the pocket 5 using forceps or the insertion tool 20 described below. If required, the implant 1 is rotated inside the pocket 5 in the direction of rotation 32 by 90° about its vertical axis, which is possible due to the fact that the different layers of the eyeball merely lie on top of one another but are not stuck together.
  • The stability of the eye's shape is due to the intraocular pressure. Rotating the implant has the advantage of allowing the telemetry coil 8 contained in the implant to be brought into an advantageous position, as far forward as possible and directly behind the pars plana, the long side being in parallel therewith. The implant 1 is thus either in parallel with the viewing direction 9 and therefore aligned with the optical axis of the eye 2, or it is rotated by 90° relative to the viewing direction 9 and therefore oriented in parallel with the pars plana. The aim is to position the implant as far forward as possible so that it can be reached as easily as possible by the telemetry.
  • The surgically produced sclera aperture does not necessarily have to be closed after the implant 1 has been positioned. Normally, the sclera will grow back of its own accord without further intervention. If required, however, it can be closed by means of a suture, biological adhesive, or the like.
  • As can be seen best in FIGS. 3 and 4, the implant 1 has an electrical pressure sensor 6 for measuring the intraocular pressure, a microchip 7 on which the pressure sensor 6 is attached and connected to the microchip 7, and an antenna 8 in the form of an electrical coil that is made of insulating gold wire and supported by spacers 10. The gold wire is wound around the microchip 7 in a plurality of turns. The housing 11 of the implant 1 is moulded from synthetic resin or formed of silicone rubber, the above-mentioned components being enclosed therein. In particular, the implant could, for example, be embedded in a plurality of layers of silicone rubber having varying degrees of hardness in order to achieve greater stability. In this case, a sensor-side layer is made of softer material and a back layer is made of harder material. The housing 11 is flat and elongate and is in the shape of a cuboid having rounded corners and edges, and nubs on one housing side. The length 12 of the housing 11 is approximately 6 mm, its width 13 is approximately 3 mm and its thickness 14 is approximately 1.5 mm. The housing 11 is provided with three nubs 17 on an outer housing side 15 that faces the sclera 3 of the eye 2 in the implanted state, the nubs being arranged in the manner of the corners of a triangle. As a result, the same implant 1 can be used for eyes 2 of varying sizes, the sclera 3 of which is concavely curved to varying degrees on its inner side without the degree of curvature having a significant influence on the mechanical tension to which the implant 1 is exposed in the eye 2. As a result, the accuracy of the pressure measurement is improved.
  • The pressure sensor 6 is arranged on the other outer housing side 16 of the housing 11 that faces the choroid 4 in the implanted state. A flexible membrane 18 is located between the pressure sensor 6 and the choroid 4 as a protective layer against ingress of liquid. The membrane 18 presses against the pressure-sensitive surface of the pressure sensor 6 and, on the other side, against the choroid 4. The pressure sensor 6 is thus in full-surface contact with the choroid 4 via the membrane 18.
  • The implant 1 lies in the eye 2 in a tension-free manner between the sclera 3 and the choroid 4. Due to physiological ocular pressure and force relationships, the intraocular pressure also fixes the implant 1 in place by means of the choroid 4. The choroid 4 lies on the membrane 18 of the planarly extended pressure sensor 6 as a thin, soft choroid coat. As a result, the coupling between the pressure sensor 6 and the aqueous humour of the vitreous body of the eye 2 is not, or is only insignificantly, affected. The implant 1 therefore does not measure the pressure in the suprachoroidal space, but rather in the inner eye.
  • Furthermore, the implant 1 is provided with a temperature sensor 19 that is attached to the microchip 7. The temperature sensor 19 is used for measuring the temperature of the eye in the suprachoroidal space. Just like the electrical signals of the pressure sensor 6, the electrical signals of the temperature sensor 19 are registered by the microchip 7 and digital data are generated in which the temperature values and pressure values are encoded. The digital data are transmitted by the antenna 8, using electromagnetic waves, to a receiver located outside the eye 2. The pressure and temperature data can be saved in and analysed by the receiver. Analysis of the temporal progression of the pressure or temperature is thus also possible.
  • In a variant, as shown in FIG. 5, the outer housing side 16 of the housing 11 of the implant 1 that faces the choroid can be concave. The outer housing side 15 of the housing 11 opposite the sclera 3 is convex in the embodiment shown. The design can take one form or the other, depending on the requirements. Thus, the convex and concave sides can also be arranged vice versa, or both sides can be convex or both sides can be concave.
  • LIST OF REFERENCE NUMERALS
    • 1 Implant
    • 2 Eye
    • 3 Sclera
    • 4 Choroid
    • 5 Pocket/cavity
    • 6 Pressure sensor
    • 7 Microchip
    • 8 Antenna/coil
    • 9 Viewing direction
    • 10 Spacer
    • 11 Housing
    • 12 Length
    • 13 Width
    • 14 Thickness
    • 15 Outer housing side
    • 16 Outer housing side
    • 17 Nubs
    • 18 Membrane
    • 19 Temperature sensor

Claims (15)

1. Implant for determining intraocular pressure, comprising at least one electrical pressure sensor (6) for measuring the intraocular pressure, at least one microchip (7) that is connected to the pressure sensor (6), and at least one antenna (8) that is connected to the microchip (7), the microchip (7) generating digitally encoded data from the electrical signals of the pressure sensor (6), which data can be transmitted by the antenna (8), using electromagnetic waves, to a receiver located outside the eye (2), and said components being accommodated in a small housing (11), the outer dimensions (12, 13, 14) of which are limited such that the implant (1) can be positioned between the sclera (3) and the choroid (4) of the eye (2), characterised in that the pressure sensor (6) is accommodated on an outer housing side (16) of the implant (1), which outer housing side is brought into contact with the choroid (4) in the eye (2).
2. Implant according to claim 1, characterised in that the outer housing side (16) provided with the pressure sensor (6) comprises a flexible membrane (18) in the region of the pressure sensor (6) as a protective layer against ingress of liquid, the intraocular pressure acting on the pressure sensor (6) via the choroid (4) and the membrane (18).
3. Implant according to claim 1, characterised in that the housing (11) thereof is flat and elongate, preferably in the shape of an ellipsoid or cuboid having rounded corners and edges.
4. Implant according to claim 3, characterised in that the length (12) of the housing (11) is less than 7 mm, its width (13) is less than 3.5 mm and its thickness (14) is less than 2 mm.
5. Implant according to claim 1, characterised in that the housing (11) is moulded from plastics material.
6. Implant according to claim 1, characterised in that the housing (11) is provided with suture loops on the outside for fixing the implant (1) in the eye (2).
7. Implant according to claim 1, characterised in that the housing (11) comprises nubs (17) on the outer housing side (15) facing the sclera (3), which nubs are arranged in the manner of the corners of a triangle.
8. Implant according to claim 1, characterised in that the housing (11) is concave on the outer housing side (16) thereof facing the choroid (4).
9. Implant according to claim 1, characterised in that it is provided with an electronic temperature sensor (19) that is connected to the microchip (7) and is intended for measuring the temperature of the eye, and in that the microchip (7) generates data from the electrical signals of the temperature sensor (19), which data can be transmitted by the antenna (8), using electromagnetic waves, to the receiver located outside the eye (2).
10. Implant according to claim 1, characterised in that the antenna (8) consists of an electrical coil that surrounds the microchip (7) provided with the pressure sensor (6).
11. Implant according to claim 1, characterised in that it is coated with a pharmacologically active substance, e.g. heparin or mytocin C, in order to prevent reactions of the eye such as inflammation, coagulation, tissue formation or encapsulation that would be detrimental either to the eye or to the pressure measurement.
12. Implant according to claim 1, characterised in that it comprises an energy store that is charged from the outside by means of transformer coupling or energy harvesting (saccades).
13. Implant according to claim 1, characterised in that it is provided with at least one solar cell for charging the internal energy store.
14. Implant according to claim 1, characterised in that, as an active RFID tag, it is provided with a data store in order to carry out measurements autonomously and to save the measurement data in the data store until said data are retrieved, by means of a radio link, by a reader located outside the eye (2).
15. Pressure measurement arrangement comprising an implant (1) according to claim 1 and a reader arranged outside the eye (2) for receiving measurement data that are transmitted by the implant (1) via a radio link to a receiver of the reader, characterised in that the reader is provided with a timer, an air pressure sensor and a data store, and in that it provides the air pressure data of the air pressure sensor with a time stamp and saves said data in the data store in order to temporally assign the saved air pressure data to the intraocular pressure measurement data delivered by the implant (1) and to correct said air pressure data, with respect to air pressure influences, to the intraocular pressure.
US15/319,294 2014-06-27 2015-06-10 Implant for determining intraocular pressure Abandoned US20170127941A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102014212457.3 2014-06-27
DE102014212457.3A DE102014212457A1 (en) 2014-06-27 2014-06-27 Implant for the determination of intraocular pressure
PCT/EP2015/062976 WO2015197364A1 (en) 2014-06-27 2015-06-10 Implant for determining intraocular pressure

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/062976 A-371-Of-International WO2015197364A1 (en) 2014-06-27 2015-06-10 Implant for determining intraocular pressure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/375,711 Continuation US12318143B2 (en) 2014-06-27 2021-07-14 Implant for determining intraocular pressure

Publications (1)

Publication Number Publication Date
US20170127941A1 true US20170127941A1 (en) 2017-05-11

Family

ID=53373462

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/319,294 Abandoned US20170127941A1 (en) 2014-06-27 2015-06-10 Implant for determining intraocular pressure
US17/375,711 Active US12318143B2 (en) 2014-06-27 2021-07-14 Implant for determining intraocular pressure

Family Applications After (1)

Application Number Title Priority Date Filing Date
US17/375,711 Active US12318143B2 (en) 2014-06-27 2021-07-14 Implant for determining intraocular pressure

Country Status (7)

Country Link
US (2) US20170127941A1 (en)
EP (1) EP3975822A1 (en)
JP (1) JP2017522155A (en)
AU (1) AU2015281158B2 (en)
CA (1) CA2950819A1 (en)
DE (1) DE102014212457A1 (en)
WO (1) WO2015197364A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019068026A1 (en) 2017-09-29 2019-04-04 Glaukos Corporation Intraocular physiological sensor
US10709547B2 (en) 2014-07-14 2020-07-14 Ivantis, Inc. Ocular implant delivery system and method
US11197779B2 (en) 2015-08-14 2021-12-14 Ivantis, Inc. Ocular implant with pressure sensor and delivery system
CN114569063A (en) * 2022-04-24 2022-06-03 明澈生物科技(苏州)有限公司 Intraocular pressure sensor
US20220211269A1 (en) * 2014-07-01 2022-07-07 Injectsense, Inc. Methods and Devices for Implantation of Intraocular Pressure Sensors
US11497399B2 (en) 2016-05-31 2022-11-15 Qura, Inc. Implantable intraocular pressure sensors and methods of use
US11540940B2 (en) 2021-01-11 2023-01-03 Alcon Inc. Systems and methods for viscoelastic delivery
US11744734B2 (en) 2007-09-24 2023-09-05 Alcon Inc. Method of implanting an ocular implant
US11938058B2 (en) 2015-12-15 2024-03-26 Alcon Inc. Ocular implant and delivery system
US12029683B2 (en) 2018-02-22 2024-07-09 Alcon Inc. Ocular implant and delivery system
US12042432B1 (en) 2024-01-11 2024-07-23 Michael Reynard Method and device for the treatment of glaucoma
CN119499038A (en) * 2023-08-25 2025-02-25 苏州朗目医疗科技有限公司 Eye implant
US12274640B1 (en) 2024-11-08 2025-04-15 Michael Reynard Implant for electrolysis of aqueous humor
US12419738B2 (en) 2010-02-23 2025-09-23 Alcon Inc. Fluid for accommodating intraocular lenses

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4193907A1 (en) 2011-09-13 2023-06-14 Glaukos Corporation Intraocular physiological sensor
US9730638B2 (en) 2013-03-13 2017-08-15 Glaukos Corporation Intraocular physiological sensor
WO2017164982A1 (en) * 2016-03-21 2017-09-28 The Regents Of The University Of California Real-time and continuous measurement in vivo using aptamer-based biosensors
DE102017107579A1 (en) 2017-04-07 2018-10-11 Implandata Ophthalmic Products Gmbh Partially flexible device for determining intraocular pressure for implantation in the human body
WO2019219193A1 (en) 2018-05-16 2019-11-21 Implandata Ophthalmic Products Gmbh Partially flexible device for determining interocular pressure for implanting in the human body
US11701019B2 (en) * 2019-03-27 2023-07-18 Glaukos Corporation Intraocular physiological sensor
DE102019119913A1 (en) * 2019-07-23 2021-01-28 Implandata Ophthalmic Products Gmbh Arrangement and method for capturing a field of view and use of an implant

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4253199A (en) * 1978-09-25 1981-03-03 Surgical Design Corporation Surgical method and apparatus for implants for the eye
US4642114A (en) * 1983-05-16 1987-02-10 Rosa Daniele S A Posterior chamber intraocular lens
US5520631A (en) * 1994-07-22 1996-05-28 Wound Healing Of Oklahoma Method and apparatus for lowering the intraocular pressure of an eye
US20030078487A1 (en) * 2001-08-09 2003-04-24 Jeffries Robert E. Ocular pressure measuring device
US20040059248A1 (en) * 2001-01-17 2004-03-25 Arthur Messner Implant for determining intra-ocular pressure
US6939299B1 (en) * 1999-12-13 2005-09-06 Kurt Petersen Implantable continuous intraocular pressure sensor
US20110248671A1 (en) * 2010-04-08 2011-10-13 Alcon Research, Ltd. Power System Implantable in Eye
US20120004528A1 (en) * 2010-07-02 2012-01-05 Alcon Research, Ltd. Implantable Remote Monitoring Sensor
US20120226133A1 (en) * 2009-09-18 2012-09-06 Orthomems, Inc. Implantable mems intraocular pressure sensor devices and methods for glaucoma monitoring
US20140275923A1 (en) * 2013-03-13 2014-09-18 David S. Haffner Intraocular physiological sensor
US8926510B2 (en) * 2011-04-27 2015-01-06 Istar Medical Sa Device and method for glaucoma management and treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19728069C1 (en) 1997-07-01 1999-02-11 Acritec Gmbh Device for measuring intraocular pressure
AR032840A1 (en) 2001-02-23 2003-11-26 Ras Holding Corp SURGICAL SHEET USED WITH A SURGICAL INSTRUMENT TO MAKE INCISIONS IN IMPLANTS IN EYE SCLERTIC
US20050159660A1 (en) * 2002-05-31 2005-07-21 Valentino Montegrande Intraocular pressure sensor
JP4258657B2 (en) * 2002-08-08 2009-04-30 グローコス コーポレーション Implantable eye pump to reduce intraocular pressure
WO2005027906A1 (en) * 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US8475374B2 (en) * 2007-08-23 2013-07-02 Purdue Research Foundation Intra-occular pressure sensor
JP2013505078A (en) * 2009-09-18 2013-02-14 オーソメムス, インコーポレイテッド Implantable ophthalmic MEMS sensor device and method for ophthalmic surgery
US20120022505A1 (en) * 2010-07-20 2012-01-26 Bruno Dacquay Closed loop glaucoma drug delivery system
DE102010035294A1 (en) * 2010-08-25 2011-12-22 Implandata Ophthalmic Products Gmbh Sclera sensor
KR20140089506A (en) * 2011-06-30 2014-07-15 엔도트로닉스, 인코포레이티드 Implantable sensor enclosure with thin sidewalls
EP4193907A1 (en) * 2011-09-13 2023-06-14 Glaukos Corporation Intraocular physiological sensor
US9339187B2 (en) * 2011-12-15 2016-05-17 Alcon Research, Ltd. External pressure measurement system and method for an intraocular implant
US9046699B2 (en) * 2012-03-13 2015-06-02 Johnson & Johnson Vision Care, Inc. Dynamic fluid zones in contact lenses
US9486132B2 (en) 2013-01-17 2016-11-08 Abbott Cardiovascular Systems, Inc. Access device for accessing tissue
WO2015085234A1 (en) * 2013-12-06 2015-06-11 Forsight Vision4, Inc. Implantable therapeutic devices

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4253199A (en) * 1978-09-25 1981-03-03 Surgical Design Corporation Surgical method and apparatus for implants for the eye
US4642114A (en) * 1983-05-16 1987-02-10 Rosa Daniele S A Posterior chamber intraocular lens
US5520631A (en) * 1994-07-22 1996-05-28 Wound Healing Of Oklahoma Method and apparatus for lowering the intraocular pressure of an eye
US6939299B1 (en) * 1999-12-13 2005-09-06 Kurt Petersen Implantable continuous intraocular pressure sensor
US20040059248A1 (en) * 2001-01-17 2004-03-25 Arthur Messner Implant for determining intra-ocular pressure
US20030078487A1 (en) * 2001-08-09 2003-04-24 Jeffries Robert E. Ocular pressure measuring device
US20120226133A1 (en) * 2009-09-18 2012-09-06 Orthomems, Inc. Implantable mems intraocular pressure sensor devices and methods for glaucoma monitoring
US20110248671A1 (en) * 2010-04-08 2011-10-13 Alcon Research, Ltd. Power System Implantable in Eye
US20120004528A1 (en) * 2010-07-02 2012-01-05 Alcon Research, Ltd. Implantable Remote Monitoring Sensor
US8926510B2 (en) * 2011-04-27 2015-01-06 Istar Medical Sa Device and method for glaucoma management and treatment
US20140275923A1 (en) * 2013-03-13 2014-09-18 David S. Haffner Intraocular physiological sensor

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11744734B2 (en) 2007-09-24 2023-09-05 Alcon Inc. Method of implanting an ocular implant
US12016796B2 (en) 2007-09-24 2024-06-25 Alcon Inc. Methods and devices for increasing aqueous humor outflow
US12419738B2 (en) 2010-02-23 2025-09-23 Alcon Inc. Fluid for accommodating intraocular lenses
US20220211269A1 (en) * 2014-07-01 2022-07-07 Injectsense, Inc. Methods and Devices for Implantation of Intraocular Pressure Sensors
US10709547B2 (en) 2014-07-14 2020-07-14 Ivantis, Inc. Ocular implant delivery system and method
US11197779B2 (en) 2015-08-14 2021-12-14 Ivantis, Inc. Ocular implant with pressure sensor and delivery system
US11938058B2 (en) 2015-12-15 2024-03-26 Alcon Inc. Ocular implant and delivery system
US11497399B2 (en) 2016-05-31 2022-11-15 Qura, Inc. Implantable intraocular pressure sensors and methods of use
AU2018338994B2 (en) * 2017-09-29 2024-03-28 Glaukos Corporation Intraocular physiological sensor
US11857262B2 (en) 2017-09-29 2024-01-02 Glaukos Corporation Intraocular physiological sensor
WO2019068026A1 (en) 2017-09-29 2019-04-04 Glaukos Corporation Intraocular physiological sensor
EP3687374A4 (en) * 2017-09-29 2021-07-07 Glaukos Corporation INTRAOCULAR PHYSIOLOGICAL SENSOR
CN111801045A (en) * 2017-09-29 2020-10-20 格拉科斯公司 Intraocular Physiological Sensors
US12029683B2 (en) 2018-02-22 2024-07-09 Alcon Inc. Ocular implant and delivery system
US11540940B2 (en) 2021-01-11 2023-01-03 Alcon Inc. Systems and methods for viscoelastic delivery
US12336933B2 (en) 2021-01-11 2025-06-24 Alcon Inc. Systems and methods for viscoelastic delivery
CN114569063A (en) * 2022-04-24 2022-06-03 明澈生物科技(苏州)有限公司 Intraocular pressure sensor
US12257079B2 (en) 2022-04-24 2025-03-25 Mingche Biotechnology Co., Ltd Intraocular pressure sensor
CN119499038A (en) * 2023-08-25 2025-02-25 苏州朗目医疗科技有限公司 Eye implant
US12042432B1 (en) 2024-01-11 2024-07-23 Michael Reynard Method and device for the treatment of glaucoma
US12274640B1 (en) 2024-11-08 2025-04-15 Michael Reynard Implant for electrolysis of aqueous humor

Also Published As

Publication number Publication date
WO2015197364A1 (en) 2015-12-30
EP3975822A1 (en) 2022-04-06
CA2950819A1 (en) 2015-12-30
US12318143B2 (en) 2025-06-03
JP2017522155A (en) 2017-08-10
AU2015281158B2 (en) 2019-07-25
DE102014212457A1 (en) 2015-12-31
US20210361161A1 (en) 2021-11-25
AU2015281158A1 (en) 2016-12-15

Similar Documents

Publication Publication Date Title
US12318143B2 (en) Implant for determining intraocular pressure
US20230024683A1 (en) Implantable intraocular pressure sensors and methods of use
US8894578B2 (en) Implantable MEMs intraocular pressure sensor devices and methods for glaucoma monitoring
US8182435B2 (en) Intraocular pressure sensor
JP6133294B2 (en) Processor-controlled intraocular lens system
ES2973275T3 (en) Systems to monitor eye health
US10213107B2 (en) Methods and devices for implantation of intraocular pressure sensors
US8527055B2 (en) Application of an electrical field in the vicinity of the trabecular meshwork to treat glaucoma
WO2012037455A1 (en) Expandable implantable pressure sensor for intraocular surgery
US20040098123A1 (en) Bulbous scleral implants for the treatment of eye disorders such as presbyopia and glaucoma
ES3034161T3 (en) Electrical apparatus for an eye
JP2017520337A (en) Ultra-low power rechargeable implantable sensor with wireless interface for patient monitoring
JP2004520119A (en) Implants for determining intraocular pressure
US20120004528A1 (en) Implantable Remote Monitoring Sensor
ES2812814T3 (en) Intraocular device with wirelessly coupled auxiliary electronics
WO2012157623A1 (en) Intraocular lens
US12042432B1 (en) Method and device for the treatment of glaucoma
US10863903B2 (en) Ocular system and method
US20250228707A1 (en) Method and Device for the Treatment of Glaucoma
ES2556008T3 (en) Stirrup prosthesis with spring closure
JP7104694B2 (en) Intraocular implant
US12208258B2 (en) Electrical apparatus and methods for an eye
CN107427362A (en) Noninvasive vestibular stimulation and measuring electrode

Legal Events

Date Code Title Description
AS Assignment

Owner name: IMPLANDATA OPHTHALMIC PRODUCTS GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OSTERMEIER, MAX;MEYER, STEFAN;SZURMAN, PROF. PETER;REEL/FRAME:040637/0179

Effective date: 20161128

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION